glp·helper
glphelper.com/ozempic/north-carolina/cary
GLP-1 receptor agonistFDA-approved December 2017Rx · Subcutaneous injection · Once weekly

Ozempic® providers &
prescriptions in Cary, NC

Verified Ozempic providers in Cary, NC. Checked against the NPI registry, never ranked by who pays us.[7]

average Ozempic weight loss →trial-anchored estimate
city providers
29
as of today
§ 02Provider directory: North Carolina
29 of 29 shown

Find an Ozempic provider in North Carolina.

Every entry is checked against the federal NPI registry. We do not accept payment for placement.

Filter →
Type
Provider
City
Insurance / phone
Browse by North Carolina city · /ozempic/north-carolina/{city}
§ 03Getting Ozempic in Cary
29 providers · Cary, NC

How to get Ozempic in Cary.

29 GLP-1 prescribers and 7 local resource types are on record for Cary, plus 3 nearby towns in the directory.

Prescribers in Cary
29 prescribers
29 GLP-1 prescribers in Cary, most listed as Internal Medicine (12), Family Medicine (11) and Internal Medicine, Endocrinology, Diabetes & Metabolism (5). Any North Carolina-licensed physician, nurse practitioner, or PA can prescribe Ozempic, over video or in person. The nearest towns on record are Apex (28 providers), Raleigh (40 providers) and Garner (27 providers).
Around the prescription in Cary
7 listed nearby
121 dietitians, 8 nutritionists, 6 gyms, 6 fitness clubs, 6 trainers, 6 physiotherapists and 6 places to move are on record near Cary.
Medicaid (weight loss)
Covered
As of April 2026, North Carolina Medicaid covers GLP-1s for weight loss, usually with prior authorization and BMI criteria, on top of the standard diabetes coverage. Employer and private plans vary; coverage is a plan-design choice, not a state rule.

Medicaid status above is for weight-loss use and was compiled April 2026 from KFF and public Medicaid trackers; only 13 states cover it and several are mid-change, so confirm North Carolina’s current Medicaid and plan rules before booking. GLPHelper provides information and provider matching, not medical or coverage advice.

§ 04Medication factsheet
cited · last review 2026.05.19

An injectable medication for adults with type 2 diabetes, and, by indirect effect, for body weight.

Ozempic is the brand name for semaglutide, a once-weekly subcutaneous injection in the GLP-1 receptor agonist class. It mimics a gut hormone that signals satiety to the brain and slows gastric emptying. In randomized trials it lowered HbA1c by 1.4 to 1.8 percentage points and produced a mean weight loss of 4.5 to 6.4 kg at the 1 mg dose.[2][3]

It is FDA-approved for glycemic control in adults with type 2 diabetes mellitus and for reducing the risk of major cardiovascular events in adults with T2D and established cardiovascular disease. The same molecule, marketed by the same manufacturer as Wegovy, is the FDA-approved formulation for chronic weight management.[1]

For the receptor story in plain English, read how does ozempic work.

Rapid weight loss can change the midface. The mechanism people call ozempic face is in the research notes.

At a glanceNDC 0169-4132
Generic name
semaglutide
Drug class
GLP-1 receptor agonist
Manufacturer
Novo Nordisk
FDA approved
December 2017
Approved use
Type 2 diabetes mellitus (adults)
Off-label use
Weight management (Wegovy is the FDA-approved formulation for obesity)
Administration
Subcutaneous injection · Once weekly
Available doses
0.25 mg · 0.5 mg · 1 mg · 2 mg
Half-life
≈ 7 days
Pregnancy
Discontinue ≥ 2 months before planned pregnancy

Community health · CDC

Weight & metabolic health in Cary

Cary, North Carolina has a population of 174,721 people. The adult obesity rate in Cary is an age-adjusted estimate of 24.6%, 9.9 percentage points below the North Carolina state rate of 34.5%. Diagnosed diabetes reaches 7.9% of adults in Cary. Inactivity, meaning no leisure-time physical activity reported in the past month, affects 15.4% of adults in Cary.

of Cary adults have obesity
24.6%
diagnosed diabetes
7.9%
no regular physical activity
15.4%

Age-adjusted estimates for Cary, community figures, not individual risk. CDC PLACES, 2025 release.

Estimate your weight losswhat happens after GLP-1s stop
§ 05Support around Ozempic in Cary
6 fitness clubs

The prescription is one part. Here is the rest, in Cary.

Trials of semaglutide paired the drug with diet counseling and regular activity. Every name below is a real listing near Cary, NC, ordered as the registry lists them, never by who pays us.

Fitness clubs and recreation centers

Fitness clubs and recreation centers run classes and pools, an easier start than a weight room.

Jazzercise Fitness Center of Cary
FITNESS
4.9 on Google · 70 reviews
1070 W Chatham St
Website
Oak and Iron Fitness
FITNESS
5.0 on Google · 46 reviews
302 Colonades Way Unit 101
Website
Mega Cary
FITNESS
5.0 on Google · 21 reviews
249 E Chatham St
Website
Planet Fitness
GYM
4.3 on Google · 1259 reviews
681 Cary Towne Blvd
Website
Life Time
GYM
3.6 on Google · 627 reviews
1700 Regency Pkwy
Website
Anytime Fitness
GYM
4.7 on Google · 175 reviews
1207 Kildaire Farm Rd
Website

Registered dietitians

A registered dietitian builds the food plan around your prescription. Call to ask about GLP-1 nutrition plans and insurance.

Ashley Acornley, RD, LDN
RD
Registered dietitian
6200 Falls Of Neuse Rd
Call 267-626-9379NPI 1023397551
Toni Ann Apadula
RD
Registered dietitian
4000 Blue Ridge Rd
Call 919-781-4500NPI 1992233639
Caitlin Ashley, RD
RD
Registered dietitian
8506 Six Forks Rd Ste 104
Call 571-344-0742NPI 1083377501
Ashley Bailey, RDN, LDN
RD
Registered dietitian
700 Research Drive
Call 919-531-8809NPI 1134874381
Linnet Biswas, RDN
RD
Registered dietitian
1218 Taylor Ct
Call 919-867-8893NPI 1154208726
Sarah Booth, RD, LDN
RD
Registered dietitian
219 S East St
Call 910-523-1783NPI 1407684574
§ 06Clinical evidence
N = 8,416 across SUSTAIN 1 to 7

What the trials actually showed.

We summarize results from the SUSTAIN program, the seven Phase III randomized trials Novo Nordisk submitted to the FDA, and the SUSTAIN-6 cardiovascular outcomes trial. Numbers below are means at the 30-week endpoint, 1 mg weekly dose.

SUSTAIN 1 through 7 compared semaglutide against placebo, sitagliptin, exenatide ER, insulin glargine, and dulaglutide. Semaglutide produced superior HbA1c and body-weight reductions in every active comparator trial.[3]
SUSTAIN endpoint table1 mg / 30 wk
HbA1c reduction
−1.4 to −1.8%
vs. placebo at 30 wk[3]
Weight change
−4.5 to −6.4 kg
mean, 1 mg dose[3]
Major adverse cardiac events
−26%
HR 0.74 vs. placebo[2]
Patients reaching HbA1c <7%
72%
1 mg dose, 30 wk[3]
Effect size varies with baseline characteristics and adherence. Individual response may differ materially.
average Ozempic weight loss →mapped to your starting weight
§ 07Safety & adverse events
from FDA label, sect. 6.1

Most side effects are gastrointestinal and resolve within weeks.

The most common adverse events in SUSTAIN trials were nausea (15 to 20%), diarrhea (8 to 9%), and vomiting (5 to 9%), all dose-dependent and typically transient.[1] Serious events were rare but include pancreatitis, gallbladder disease, and an FDA boxed warning regarding thyroid C-cell tumors based on rodent data.[8]

Boxed warning. Contraindicated in personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
Effect
Frequency
Severity
Note
Nausea
15 to 20%
mild
Most common; typically dose-dependent and resolves within weeks
Diarrhea
8 to 9%
mild
More frequent during dose escalation
Vomiting
5 to 9%
mild
Reduced by slower titration
Constipation
3 to 7%
mild
Abdominal pain
5 to 7%
moderate
Pancreatitis
<0.3%
serious
Discontinue if confirmed; black-box adjacent
Gallbladder disease
1.5%
serious
Cholelithiasis risk elevated with rapid weight loss
Thyroid C-cell tumors
rodent data
boxed warning
Contraindicated in MTC or MEN-2 history
§ 08Cost & coverage, published, not gated
USD · monthly

Most directories hide the price. We don't.

Cash prices vary roughly 50× between the brand-name retail rate and a manufacturer savings card. The number you actually pay depends on your insurance plan, your diagnosis code, and which pharmacy fills the script. Here are the ranges, plainly.

Data sources: GoodRx national retail survey[6], CMS Part D formulary files[5], Novo Nordisk patient access program.

Cash (no insurance)
$950 to $1,150
per month
National pharmacy average, brand-name[6]
Commercial insurance (covered)
$25 to $250
per month copay
Varies by PBM; T2D indication usually covered
Commercial insurance (off-label / weight)
Typically denied
PA required; majority denied for weight indication
Medicare Part D
$0 to $100
per month
T2D covered; weight loss not covered by law[5]
Manufacturer savings card
as low as $25
per month
Commercial only; eligibility limits apply
Compounded semaglutide
$150 to $400
per month
503A pharmacies; FDA scrutiny ongoing[8]
Updated weekly · last fetch 2026-05-18 04:00 UTCCost methodology →
Find Ozempic providers in North Carolina

NPI-verified Ozempic (semaglutide) prescribers and clinics, never ranked by who pays us.

Ozempic in other states

Find NPI-verified Ozempic (semaglutide) doctors, clinics, and pharmacies in the states we cover, never ranked by who pays us.

Related GLP-1 research
§ 09Frequently asked: Ozempic in North Carolina

The questions people ask before they book.

Answers reviewed by the GLPHelper Medical Team. Citations link to primary sources, never marketing copy.

Yes. Semaglutide is a federally scheduled prescription drug in all 50 states. A licensed prescriber (MD, DO, NP, or PA) must evaluate you before issuing a prescription. No state permits pharmacist-initiated prescribing of GLP-1s.[1]